Gilead Sciences (GILD) Retained Earnings (2009 - 2026)

Gilead Sciences (GILD) has reported Retained Earnings for 18 consecutive years, with $78.0 million the latest figure, recorded in Q1 2026.

• Retained Earnings for Q1 2026 came in at $78.0 million, down 99.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.0 million (down 99.29% YoY), and the FY2025 annual result was $39.0 million, down 70.45% from the prior year.
• Retained Earnings was $78.0 million for Q1 2026 at Gilead Sciences, up from $39.0 million in the prior quarter.
• Over five years, Retained Earnings peaked at $16.0 billion in Q3 2023 and troughed at -$18.0 million in Q2 2025.
• Average Retained Earnings over 5 years is $6.6 billion, with a median of $132.0 million recorded in 2024.
• Year-over-year, Retained Earnings jumped 111550.0% in 2024 and plunged 100.16% in 2025.
• Over 5 years, Retained Earnings stood at $15.7 billion in 2022, then tumbled by 99.82% to $28.0 million in 2023, then surged by 371.43% to $132.0 million in 2024, then plunged by 70.45% to $39.0 million in 2025, then surged by 100.0% to $78.0 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were $78.0 million in Q1 2026, $39.0 million in Q4 2025, and $12.8 billion in Q3 2025.